2016
DOI: 10.1016/j.ijmm.2015.12.002
|View full text |Cite
|
Sign up to set email alerts
|

Both clades of the epidemic KPC-producing Klebsiella pneumoniae clone ST258 share a modified galactan O-antigen type

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

6
95
1

Year Published

2016
2016
2024
2024

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 46 publications
(102 citation statements)
references
References 35 publications
6
95
1
Order By: Relevance
“…Moreover, both isolates were positive for the operon required for galactan-III synthesis that was recently described in the majority of ST258 clinical isolates [21]. …”
Section: Methodsmentioning
confidence: 87%
“…Moreover, both isolates were positive for the operon required for galactan-III synthesis that was recently described in the majority of ST258 clinical isolates [21]. …”
Section: Methodsmentioning
confidence: 87%
“…The finding that some of the isolates tested were readily killed in human blood or serum was surprising to us, since bacteremia is relatively common (among individuals with infections caused by carbapenem-resistant K. pneumoniae isolates) and ST258 isolates whose genomes encode the same capsule polysaccharide subtype (e.g., cps-2) are genetically very similar (30,39). Previous studies have shown that the Klebsiella lipopolysaccharide (LPS) O antigen and/or the capsule polysaccharide contributes to resistance to the bactericidal activity of human serum (40)(41)(42)(43)(44)(45). Merino et al proposed that the deposition of complement C3b occurs too far from the membrane of serumresistant strains of K. pneumoniae, and thus, the C5b-C9 MAC fails to form (43).…”
Section: Survival Of K Pneumoniae In Bloodmentioning
confidence: 99%
“…In contrast to most Gram-negative bacteria, variability of K. pneumoniae O-antigens is currently limited to 9 major O-serotypes: O1, O2, O2ac, O3, O4, O5, O7, O8, O12 (Hansen et al, 1999) and a few subtypes within these serogroups (Kelly and Whitfield, 1996). However, the occurrence of modified or novel O-antigen structures has been forecasted recently (Follador et al, 2016; Szijarto et al, 2016). Since O-antigens are far less variable than CPS, Klebsiella LPS O-antigens have been suggested as potential target antigens for immunotherapy as an alternative to antibiotic treatment (Rukavina et al, 1997; Trautmann et al, 1997, 2004; Hsieh et al, 2014; Follador et al, 2016; Szijarto et al, 2016).…”
Section: Introductionmentioning
confidence: 99%
“…It was shown previously for the O2 serotype that d -gal-I can be decorated by stoichiometric and non-stoichiometric addition of O-acetyl or terminal d -galactose (Kelly et al, 1995). Recent studies revealed the frequent occurrence of gal-I backbone RU decorated by the terminal α- d -Gal p residue, termed as d -galactan-III (gal-III), within the O2 serogroup and the genetic background for this modification has been identified (Szijarto et al, 2016). It was shown that conversion of gal-I to gal-III is encoded by gmlABC , which is carried adjacent to the gal-I-encoding rfb ( wb ) operon.…”
Section: Introductionmentioning
confidence: 99%